Compounds and methods for inhibiting EMT pathways to treat cancer, organ fibrosis and metabolic disorders
申请人:University of Pittsburgh—Of the Commonwealth System of Higher Education
公开号:US11078159B2
公开(公告)日:2021-08-03
A compound, or a pharmaceutically acceptable salt or isomer thereof, of Formula I:
wherein R is hydrogen, alkyl, substituted alkyl, alkenyl, or substituted alkenyl;
R1 is hydrogen, alkoxy, or substituted alkoxy;
R2 is hydrogen, alkyl, or substituted alkyl; and
R3 is hydrogen, alkyl, or substituted alkyl.
式 I 的化合物或其药学上可接受的盐或异构体:
其中 R 是氢、烷基、取代烷基、烯基或取代烯基;
R1 是氢、烷氧基或取代的烷氧基
R2 是氢、烷基或取代烷基;和
R3 是氢、烷基或取代的烷基。